MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$22,260K
EPS
-$0.11
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Collaboration revenue
NaN 0 NaN NaN
Research and development
NaN 19,702 22,526 26,859
General and administrative
NaN 955 6,835 7,805
Impairment of long-lived assets
NaN 0 6,763 NaN
Total operating expenses
NaN 20,657 36,124 34,664
Loss from operations
NaN -20,657 -36,124 -34,664
Interest income
NaN 1,309 1,605 2,010
Other income
NaN 103 97 113
Total other income
NaN 1,412 1,702 2,123
Loss before provision for income taxes
NaN -19,245 -34,422 -32,541
Personnel and related costs
5,596 NaN NaN NaN
Facility and other allocated costs
3,468 NaN NaN NaN
Research and laboratory
7,468 NaN NaN NaN
Other research and development
573 NaN NaN NaN
General and administrative
6,579 NaN NaN NaN
(benefit) provision for income taxes
NaN -68 NaN NaN
Other segment (income) expense
-2,039 NaN NaN NaN
Net income (loss)
-21,645 -19,177 -34,422 -32,541
Unrealized loss on investments
-615 -34 -19 -222
Comprehensive income (loss)
-22,260 -19,211 -34,441 -32,763
Basic EPS
-0.11 -0.22 -0.4 -0.38
Diluted EPS
-0.11 -0.22 -0.4 -0.38
Basic Average Shares
193,474,913 87,502,722 86,464,066 86,238,084
Diluted Average Shares
193,474,913 87,425,291 86,464,066 86,238,084
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive income (loss)-$22,260K (-129.08%↓ Y/Y)Net income (loss)-$21,645K (-128.27%↓ Y/Y)Unrealized loss oninvestments-$615K (-3136.84%↓ Y/Y)Other segment(income) expense-$2,039K (14.47%↑ Y/Y)Research and laboratory$7,468K (-21.18%↓ Y/Y)General andadministrative$6,579K (-21.75%↓ Y/Y)Personnel and relatedcosts$5,596K (-43.95%↓ Y/Y)Facility and otherallocated costs$3,468K (-34.84%↓ Y/Y)Other research anddevelopment$573K (-68.15%↓ Y/Y)

Century Therapeutics, Inc. (IPSC)

Century Therapeutics, Inc. (IPSC)